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1. Introduction 
The response of cells to even slight changes in the cellular microenvironment determines the 
reaction of the whole organism and its ability to adapt to macroenvironmental alterations. 
Generally, it is well recognized that the communication between cells, tissues, and organs is 
critical for the maintenance of the entire body homeostasis. The different cell types that 
build the various organs and tissues have an enormous potential to produce proteins that 
once secreted in the extracellular space exert their action in an auto-, para- and/or endocrine 
manner. It is estimated that out of the total 20.500 protein-coding genes in human, 
approximately 10% encode secreted proteins (Clamp et al., 2007; Skalnikova et al., 2011). The 
separate and combinatorial action of these ~2200 secreted proteins can influence the biology 
not only at adjacent sites but also have a clear effect on the whole organism (Lin et al., 2008). 
The secreted factors, which can range from large proteins to short peptides, are divided into 
different groups or classes according to their structural properties and function. The 
prototypical secreted proteins are represented by the group of proteins found in the blood 
stream and other body fluids, the components of the extracellular matrix (ECM) and 
enzymes released in the intestine and stomach. An intriguing group of secreted factors 
comprise cell surface receptor ligands, such as hormones, growth factors, and cytokines. 
These proteins can exert their actions either on a limited number of responsive tissues or can 
act on virtually all cell types dependent on the expression of their specific receptors. It is 
essential to decipher in depth the signaling events that are triggered by the various 
hormones and growth factors to understand the general mechanisms of the biological 
processes that occur in a strictly controlled fashion in both space and time. The processes 
that secreted factors influence and directly regulate range from cellular differentiation, 
growth and survival to apoptosis, autophagy, and ageing. In addition, a growth factor can 
often exert a divergent and even opposite effect depending on the cell type and cellular 
state. Taken in consideration the role of secreted factors in directing biological processes, 
malfunction of the signaling cascades orchestrated by secreted factors can have severe 
consequences and lead to development of a series of complicated diseases and disorders 
(Flier, 2001; Pedersen, 2009; Walsh, 2009). Therefore, a comprehensive characterization of 
secreted molecules by different cellular subtypes, tissues, and organs can contribute to the 
elucidation of the physiological state of a given organism and to the determination of the 
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malfunction in diseased stages. Analyzing on a large scale and in an unbiased manner the 
secretome of any given cell type or tissue, which comprise a unique combination of growth 
factors, hormones, cytokines, inhibitory factors, and components of the extracellular 
environment, has become a whole distinct research field. Although still challenging, this 
endeavor may ultimately prove beneficial for improving human health as it can accelerate 
the bridging of basic research and applied medicine. 
2. Proteomics 
Proteomics has many sides and it is often difficult to combine the different aspects that can 
define or characterize this broad topic. The term proteomics was introduced in 1995, 
describing the entire set of proteins expressed by a given cell, tissue, or organism (Wasinger 
et al., 1995). At present, proteomics is defined as large scale studies of the proteomes that 
encompass protein expression, folding, and localization. It also includes functional analyses 
of large complexes within a cell, tissue, or organism as well as comparison of different 
proteomes. Some of the different aspects of proteomics include analysis of body fluids, 
defining proteomes of pathogens, investigation of tissue proteomes, characterization of 
signaling pathways and the effects of inhibitors and drugs. The term systems biology was 
also introduced to describe the incorporation of genomics, metabolomics, and proteomics 
data for creation of dynamic networks of interacting molecules at a system level. Typically, 
such studies involve following the changes in protein profiles in response to changes in the 
environment and determination of combined action of diverse signaling networks that lead 
to a differential outcome for the living organism. Obtaining and combining information for 
such networks is of particular importance when investigating the role of secreted factors in 
the regulation of major signaling events in any given cell or tissue. Functional quantitative 
mass spectrometry-based proteomics (QMSP) is a powerful approach for creation of maps 
that describe the differential expression and dynamic changes of secretomes. Correlation  of  
these  results  with  clinics  can  help resolve  some  of  the  still  missing  links  in  the 
development of different syndromes. In this review chapter, we focus on the latest advances 
in QMSP for the investigation of secreted factors and we discuss some of the issues and 
challenges that remain to be unveiled. 
2.1 Quantitative mass spectrometry-based proteomics 
The fast development of QMSP techniques added yet another dimension to the proteomic 
research, namely the ability to follow differences and changes of the proteomes in space and 
time (Aebersold and Mann, 2003; Cox and Mann, 2007; Dengjel et al., 2009). QMSP permits 
observation and investigation of a combination of events and interplay of pathways 
involving hundreds of molecules that lead to a defined outcome for the cell. It facilitates 
determination of even slight changes in protein expression or post-translational 
modifications as a result of a drug treatment, changes in the cellular environment or 
alterations in the total body homeostasis. Up to date, QMSP is the only available approach 
that can, with high confidence and in a high throughput manner, generate and combine data 
for the spatial and temporal order of events that take place in a cell directly at protein level 
in order to decipher dynamic complex processes (Dengjel et al., 2009; Rigbolt and Blagoev, 
2010; Walther and Mann, 2010). There are two main QMSP strategies for relative 
quantitation based either on the use of stable isotopes or the label-free approach for 
www.intechopen.com
 
Quantitative Proteomics for Investigation of Secreted Factors: Focus on Muscle Secretome 419 
quantitation of changes in protein abundance (Ong and Mann, 2005; Schulze and Usadel, 
2010; Walther and Mann, 2010). 
2.1.1 Quantitation without stable isotopes 
Quantitation without stable isotopes generally encompasses a gel electrophoresis approach 
or a chromatography-based approach. In the gel-based approach one-dimensional or two-
dimensional gel electrophoresis is used as a mean of resolving the proteins from complex 
mixtures. This is followed by visualization of the protein bands or spots using different 
types of stains or fluorescent dyes. Typically, the protein samples originating from different 
cellular stages are separated on a gel and then the bands or spots that show distinct changes 
are excised, digested with proteases and identified by mass spectrometry. A major 
disadvantage of two dimensional gel electrophoresis is the relatively low dynamic range 
and inefficient access into the gel of high or very low molecular weight proteins. This results 
in the identification of mainly high abundant molecules, such as cytoskeletal proteins and 
highly expressed metabolic enzymes (Gygi et al., 2000). Reducing the complexity of the 
sample can at least partially overcome such limitation. The introduction of the difference in 
gel electrophoresis (DIGE) approach, which allows proteins from two different samples to 
be separated on the same gel, led to improved quantitatively accuracy of this gel-based 
approach (Unlu et al., 1997).  
The chromatography approach can be divided into two groups, namely peptide-based 
methods and protein-based methods. The peptide-based strategy relies on comparing the 
signal intensity of a peptide originating from one sample to the signal intensity of the same 
peptide originating from a different sample. The extracted ion chromatogram (XIC) for 
every peptide can be derived from the liquid chromatography profile of the two individual 
samples during the analysis by the mass spectrometer and the samples can thereby be 
compared quantitatively. Furthermore, a method called protein correlation profiling was 
established, where the total ion chromatograms of different samples are aligned and 
quantitative comparison of samples is then based on both retention time and accurate mass 
of the peptides. The relative protein quantitation is based on the fact that the peak areas 
obtained from liquid chromatography mass spectrometry correlate to the relative 
concentration of the protein in the sample (Andersen et al., 2003; Ong and Mann, 2005). It 
has been used to obtain semi quantitative data in complex mixtures such as human sera 
(Chelius and Bondarenko, 2002). A disadvantage is that it is only partially quantitative and 
requires highly reliable and reproducible analysis of the samples.  
Another label-free mass spectrometry-based approach used to retrieve quantitative 
measurements is based on spectral count. The “spectral counting” method uses the numbers 
of peptide identification spectra obtained for each protein as representation of the protein 
abundance in a mixture (Liu et al., 2004). One disadvantage of the spectral count method is 
that it is biased toward high abundant proteins since they can mask or suppress the low-
abundance ones in the sample, which is a key issue when analyzing e. g. plasma samples. 
The two label-free methods for quantitation, using either peptide ion intensities or spectral 
counts, are becoming increasingly popular, since they are simpler than the isotope-based 
strategy, despite being less accurate. In addition, both methods require very good 
reproducibility between the different liquid chromatography tandem mass spectrometry 
(LC-MS/MS) runs, high accuracy measurements and higher number of replica analyses. In 
general, the label-free approaches are widely applicable but the methods using stable 
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isotope labels result in better accuracy of quantitation (Lundgren et al., 2010; Schulze and 
Usadel, 2010). 
2.1.2 Quantitation using stable isotopes 
The quantitative mass spectrometry-based methods utilizing stable isotopes can be achieved 
either by in vivo metabolic labeling or in vitro biochemical methods. The principle of the two 
labeling strategies is the generation of peptides labeled with stable isotopes that differ in mass 
from the unlabeled peptides making it possible to distinguish them within the same spectrum. 
2.1.2.1 Chemical labeling strategies 
The prototype of the chemical modification-based methodology for quantitation of protein 
is the isotope coded affinity tag (ICAT) that binds to cysteine residues  (Gygi et al., 1999). It 
employs usage of two isotopically labeled tags - one light and one heavy, which contains 
eight deuterium atoms, to distinctly label the peptides originating from two separate 
samples. The peptides originating from one sample can thereby be distinguished from the 
second sample, since the heavier tag will result in a mass shift readily observable in the 
mass spectrum. One of the advantages of ICAT is the presence of a biotin group in the light 
and heavy tags allowing selective enrichment of the labeled peptides using avidin affinity 
chromatography, thus reducing greatly the complexity of the mixture.  
ICAT has been applied to a variety of cell culture and tissue samples and has been 
demonstrated as a reliable and relatively easy applicable method for performing QMSP 
analysis. Among other applications, ICAT has been used to investigate differential 
expression profiles of microsomal proteins from naive and in vitro- differentiated human 
myeloid leukemia cells, secreted proteins during osteoclast differentiation, the dynamic 
changes of transcription factors during erythroid differentiation as well as comparison of 
livers of mice treated with different peroxisome proliferator-activated receptor agonists 
(Brand et al., 2004; Han et al., 2001; Kubota et al., 2003; Tian et al., 2004). Disadvantages of 
the ICAT strategy are that it targets only the cysteine containing peptides and the retention 
times of the light and heavy form during chromatographic separation are altered due to the 
presence of the deuterium atoms. To overcome some of those problems, a cleavable 12C- 
and 13C-based reagent (cICAT) has been developed, which has an improved peptide co-
elution profile during the liquid chromatography separation and increased recovery after 
enrichment of the labeled peptides (Yi et al., 2005).  
Several other chemical labeling strategies have been developed over the recent years. 
Probably the most popular of those being the isobaric tags for relative and absolute 
quantitation (iTRAQ) where the isobaric chemical groups are attached to the primary amine 
groups of the peptides. With iTRAQ, up to eight different conditions can be compared 
simultaneously since eight distinct isobaric tags for labeling are currently available. The 
quantitation is based on the intensities of the isotopically distinct fragments derived from 
the corresponding isobaric tags obtained in the peptide fragmentation spectrum. This is the 
main advantage of the method but it can also be a disadvantage since often a single 
fragment spectrum per peptide is available, thereby compromising the accuracy of 
quantitation (Ross et al., 2004).  
2.1.2.2 Metabolic labeling 
The metabolic labeling strategies rely on the incorporation of a stable isotope in proteins, 
while they are being de novo synthesized in the cell. In contrast to the standard radioactivity-
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based assays, the stable isotope is fully incorporated thereby encoding the whole proteome. 
There are two means of introducing the stable isotope using either media containing 15N 
labeled ammonium sulfate or media with the addition of a stable isotope labeled amino 
acid. The 15N labeling strategy has been used for quantitative analysis of protein 
phosphorylation in bacteria and a mouse melanoma cell line (Conrads et al., 2001; Oda et al., 
1999). Additionally, entire organisms have been metabolically labeled using the 15N 
strategy, including bacteria (E. coli and Deinococcus), C. elegans, D. melanogaster, and rat 
(Conrads et al., 2001; Krijgsveld et al., 2003; Wu et al., 2004). 
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) is an accurate and 
resourceful quantitative proteomics platform, that in combination with high speed and 
accuracy mass spectrometry allows detailed characterization of complex biological systems 
(Ong et al., 2002; Ong et al., 2003). It involves usage of heavy non-  radioactive stable 
isotope-labeled amino acids, which are incorporated directly into the newly synthesized 
proteins of the cell. After SILAC labeling, the entire proteome of a given cell population 
becomes encoded either with a light or heavier version of the same amino acid, thereby 
enabling direct comparison and quantitation using mass spectrometry. With SILAC, the 
“light” and “heavy” samples can be mixed in equal ratios at the initial stages of the 
workflow, which can include subsequent protein purification, interaction assay or other 
manipulation of the mixed sample. Combining samples prior to any further sample 
preparation represents a tremendous advantage, since it results in reduced quantitation 
errors introduced by differences in individual sample handling. Major strength of the SILAC 
method is the ability to discriminate true interaction partners from background, when 
investigating functional protein-protein interactions (Blagoev et al., 2003; Dengjel et al., 
2010). Therefore, it facilitates investigation of cellular signaling cascades and creation of 
reliable protein interaction networks, which represents one of the biggest challenges in the 
field of system biology (Blagoev et al., 2004; Dengjel et al., 2009; Kratchmarova et al., 2005; 
Olsen et al., 2006; Osinalde et al., 2011). In addition, SILAC is invaluable for the 
investigation of secreted factors since it allows the distinction of specific proteins released by 
the cells to the extracellular environment from contaminating proteins like keratins and 
serum derived factors that originate from cell culture media supplements (Henningsen et 
al., 2010). One potential disadvantage with the SILAC protocol arises from cultures of 
primary cells, which usually require specific growth media with a defined formulation. 
Furthermore, such cells have limited division capacity in culture, whereas at least 5 
population doublings are required for complete SILAC encoding of the entire proteome. 
Nevertheless, SILAC-based analyses have been successfully extended to include 
microorganisms, entire mice, and quantitation of proteins in tumor biopsies (Geiger et al., 
2010; Kruger et al., 2008; Soufi et al., 2010). It was also utilized for the quantitative analyses 
of proteins released by omental adipose tissue explants (Alvarez-Llamas et al., 2007). 
3. Application of QMSP for investigation of secreted proteins 
Analysis of secreted proteins using QMSP allows in depth characterization of different 
cellular systems that secrete auto-, para-, and endocrine factors, which can influence the 
entire body homeostasis. Investigation of cellular models such as adult and embryonic stem 
cells, cells originating from a diseased state, immortalized cells representing various models 
for functional abnormalities, extends the knowledge of how changes in secretomes 
contribute to various types of human disorders. It also enables determination and discovery 
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of new roads of tissue cross talk and interaction. QMSP has been applied to study 
secretomes of a variety of cell types and tissues including adipose cells and tissues, mouse 
embryonic fibroblasts, astrocytes, mesenchymal stem cells, neuronal progenitor cells, 
kidney, and endothelial cells (Skalnikova et al., 2011). Although, there have been several 
proteomics reports describing the secretory function of cells from mesenchymal origin, the 
role of the muscle secretome has remained elusive. A limited number of studies so far have 
employed mass spectrometry to elucidate the secretory function of the skeletal muscle. In a 
study presented by Chan and coworkers condition media (CM) was collected from 
differentiated C2C12 myotubes at day 5 of differentiation and analyzed by 1D-gel 
electrophoresis combined with matrix-assisted laser desorption/ ionization tandem mass 
spectrometry (MALDI-MS/MS) (Chan et al., 2007). This work led to the identification of 80 
proteins released from skeletal muscle of which 27 were classified as secreted proteins based 
on literature searches. In another study isolated primary human skeletal muscle cells were 
SILAC-labeled (13C6-Lys) to make a quantitative evaluation of muscle secreted proteins 
between extreme obese and lean women (Hittel et al., 2009). Assessment of the identified 
proteins based on published literature and the Swiss-Prot database revealed 28 secreted 
proteins from 42 identified skeletal muscle proteins. Interestingly, the secretion of 
myostatin, a negative regulator of skeletal muscle growth and development but also 
implicated in metabolic homeostasis, was found to be markedly upregulated in extreme 
obesity cases. Subsequently, Yoon and colleagues presented a study investigating the effects 
of insulin on the secretory profile of differentiated myotubes (Yoon et al., 2009). The authors 
combined off-line reverse-phased HPLC fractionation with LC-MS/MS and identified 153 
secreted proteins from rat L6 myotubes. Based on spectral count quantitation, 33 of these 
proteins were classified as differentially regulated in response to insulin. The list of secreted 
proteins was extracted from a total list of 254 identified proteins using three different 
prediction tools, Gene Ontology, SignalP, and SecretomeP. In two more recent studies, a 
total of 108 secreted proteins by skeletal muscle cells were identified (Chan et al., 2011; 
Norheim et al., 2011).  
We have developed a general quantitative proteomics approach for investigation of secreted 
factors released by skeletal muscle cells during the course of muscle differentiation. The 
method utilizes a combination of SILAC labeling and advanced mass spectrometry (Fig. 1) 
(Henningsen et al., 2010).  
Triple encoding SILAC, (Blagoev et al., 2004) was applied to investigate protein secretion at 
three different time points during the course of C2C12 differentiation. Initial evaluation of 
the differentiation protocol with SILAC-labeled cells demonstrated the formation of a high 
number of multinucleated myotubes and increased expression of different muscle-specific 
proteins. The use of three different versions of each labeled amino acid enabled the 
comparison of the secretome at three different time points (day 0, day 2, and day 5) during 
skeletal muscle differentiation. Furthermore, cells were cultured using both labeled arginine 
and lysine, since trypsin, which cleaves solely C-terminal to arginine and lysine, was used 
for in-gel digestion (Olsen et al., 2004). This “double-triple” labeling with isotopic forms of 
both arginine and lysine ensures that every tryptic peptide, except the C-terminal peptides 
of the proteins, contains at least one labeled residue and can therefore be used for 
quantitation (Blagoev and Mann, 2006). This increases the probability of positive protein 
identification and accuracy of quantitation due to the increased number of labeled peptides. 
It is noteworthy that under normal culture conditions cells are grown in the presence of fetal  
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Fig. 1. General outline of QMSP for the identification and quantitation of secreted proteins. 
bovine serum (FBS), but the SILAC protocol requires the use of dialyzed sera to prevent the 
presence of unlabeled sera-derived amino acids, which would ultimately result in inaccurate 
quantitation. Commercially available dFBS is dialyzed utilizing 10 kDa molecular weight 
cut off (MWCO) filters to remove any amino acids. Unfortunately, this also leads to the 
reduction of low-molecular weight proteins (<10 kDa) including certain growth factors, 
hormones, and cytokines, that may be needed for the growth and maintenance of certain 
cells. Therefore, dFBS is not compatible with all cell types and slower growth rate is 
observed in some cases. Ultimately, dialysis with MWCO 1,000 Da could be sufficient to 
remove amino acids, but it is more costly. 
The myoblasts were cultured in SILAC media for at least 5 passages to ensure complete 
incorporation of labeled amino acids into the proteome. Before the collection of 
conditioned medium (CM), cells were washed and starved for 12 hours in sera-free 
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medium to minimize the presence of sera proteins, that would interfere with the 
subsequent mass spectrometry (MS)-analysis. CM was collected from myoblasts on day 0 
and during conversion of myoblasts into myotubes at day 2 and day 5, followed by 
filtration using 0.2 µm filters to remove any floating cells or cell debris, thereby reducing 
the risk of contaminating samples with intracellular proteins. The CM, collected from the 
three time points of differentiation was combined in a 1:1:1 ratio according to measured 
protein concentration. Subsequently, the pool of CM was concentrated by ultrafiltration 
using Vivaspin columns, MWCO 3,000 Da to ensure that proteins were retained in the 
concentrate. To reduce sample complexity, thereby effectively increasing the dynamic 
range of the MS-analysis, concentrated muscle-derived proteins were separated by size 
using 1D- gel electrophoresis. The excised gel bands were subjected to in-gel digestion 
and analyzed via LC-MS/MS using an linear ion trap (LTQ)-Orbitrap mass spectrometer 
followed by processing of the obtained data with the MaxQuant software (Box 2) (Cox 
and Mann, 2008; Cox et al., 2009). The described strategy resulted in the identification of 
635 putatively secreted proteins by skeletal myoblasts based on the GO term 
“extracellular” and signal peptide prediction inbuilt in the MaxQuant and ProteinCenter. 
The commercially available database, ProteinCenter, (www. Proxeon.com) utilizes 
annotation from all major protein sequence databases including Swiss-Prot, NCBI, and 
Ensembl. It allows analysis of large scale proteomic studies to isolate putatively secreted 
factors from the total list of identified proteins. The obtained identification list of IPI 
numbers is filtered and extracted according to the category “extracellular” within GO 
term cellular component. Then, the remaining proteins are filtered using a signal peptide 
predictor incorporated into the ProteinCenter platform, the PrediSi algorithm. Using the 
SILAC strategy, 624 secreted proteins were quantitatively evaluated during the course of 
skeletal muscle differentiation. Proteins already known to be secreted by skeletal muscle 
were identified, in addition to many novel proteins not previously shown to be secreted 
by skeletal myoblasts. Characterization of identified secreted proteins according to GO-
annotations demonstrated proteins involved in many different cellular processes 
including proliferation, differentiation, ECM reorganization, metabolic processes, and 
angiogenesis. According to the statistical analyses provided by MaxQuant, 188 secreted 
proteins were found to be dynamically regulated during skeletal myogenesis suggesting 
their regulatory involvement in skeletal muscle development, which could occur both in 
autocrine and paracrine manner. In a follow up study, focused on comprehensive 
characterization of the low abundant low molecular weight fraction of proteins secreted 
by muscle cells, application of triple encoding SILAC resulted in the generation of 
quantitative profiles of 59 growth factors and cytokines, including nine classical 
chemokines (Henningsen et al., 2011). 
The depicted triple encoding SILAC strategy led to the characterization of the muscle 
secretome and creation of dynamic secretion profiles during the process of muscle 
differentiation. Among the identified secreted factors, we have found components of the 
extracellular matrix, such as collagen, fibronectin and SPARC (secreted protein acidic and 
rich in cysteine), growth factors, including members of the transforming growth factor 
and insulin-like growth factor families, members of the serpin and matrix 
metalloproteases classes, chemokines, and modulators. In addition, proteins such as 
angiopoietin-1, VEGF (Vascular endothelial growth factor), PDGF (Platelet-derived 
growth factor), and FGF21 (Fibroblast growth factor 21) were identified and quantitated. 
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Combining these results indicate that muscle is a prominent secretory organ participating 
actively in the general regulation of body homeostasis. The muscle specific secreted 
factors exert their effects in local and/or systemic manner. In Henningsen et. al., 2010 we 
have identified and characterized the semaphorins as a new family of muscle secreted 
proteins. Semaphorins constitute a large family of secreted, GPI-anchored, and 
transmembrane proteins defined by a conserved semaphorin (sema) domain in their 
amino terminus (Gherardi et al., 2004; Neufeld and Kessler, 2008; Roth et al., 2009; Serini 
et al., 2009; Suzuki et al., 2008; Zhou et al., 2008). Initially, semaphorins were described as 
important regulators of axon guidance during neuronal development. However, an 
increasing number of studies have recognized the semaphorins as pleiotropic signaling 
molecules influencing a wide array of biological processes, such as angiogenesis, immune 
responses, and organ morphogenesis. In addition, semaphorins have also been linked to 
various pathologies including cancer and different diseases of the nervous system 
(Neufeld and Kessler, 2008; Roth et al., 2009). Currently, the mammalian semaphorin gene 
family consists of 20 members and although expression of individual semaphorins has 
been best described in the nervous system, semaphorins appear to be expressed by most if 
not all  tissues (Yazdani and Terman, 2006). We have identified several members of the 
semaphorin family belonging to different subfamilies to be secreted from skeletal 
myoblasts including the soluble Sema3A, Sema3B, Sema3D, Sema3E, the transmembrane 
Sema4B, Sema4C, and Sema6A, and finally the GPI-linked Sema7A. Examination of the 
dynamic secretion profiles of the identified semaphorins demonstrated differential 
secretion of Sema3A, Sema3D, Sema3E, Sema6A, and Sema7A during the course of C2C12 
myoblast differentiation. Interestingly, secretion of Sema3A, Sema3E, Sema3D, and 
Sema6A was markedly enhanced at the early stage of the differentiation, indicating that 
they may serve a role during the initial phase of the conversion process. In contrast, a 
gradually increased secretion of Sema7A was observed during differentiation, suggesting 
that Sema7A plays a role both during early and terminal differentiation. Identification of 
both the transmembrane and GPI-anchor semaphorins in the media would suggest that 
they are released from the plasma membrane in a soluble form either by proteolytic 
shedding, in the case of Sema4 and Sema6, or proteolytic cleavage catalyzed by a 
phospholipase, in the case of Sema7A. Earlier studies have shown that the enzymatic 
activity of metalloproteases can generate and modulate the activity of a soluble form of 
Sema4D (Basile et al., 2007; Elhabazi et al., 2001). Indeed, we did observe an increased 
secretion of various proteases including MMP-2. Western blot analysis of sema6A in 
conditioned media collected from C2C12 myoblasts during differentiation supported the 
idea of Sema6A shedding, as the secreted protein migrated at an apparent molecular 
weight corresponding to the size of the extracellular domain (approx. 71 kDa) and not to 
the size of the full-length Sema6A (approx. 113 kDa). Different members of the 
semaphorin family have been shown to orchestrate the development of different organs 
including bone, lung, kidney, and the cardiovascular system (Roth et al., 2009; 
Tamagnone and Giordano, 2006). The number of studies investigating the function of 
semaphorins in skeletal muscle development and regeneration are more limited. So far, 
studies have demonstrated an enhanced expression of Sema4C but no alterations of 
Sema4B expression during C2C12 myogenesis were detected (Ko et al., 2005; Wu et al., 
2007). In addition, enhanced expression of Sema4C was also observed in vivo in injury-
induced skeletal muscle regeneration. Targeted knockdown of Sema4C expression by 
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siRNA caused inhibition of C2C12 myotube formation, demonstrating that semaphorins 
could exert an active autocrine/paracrine function in myogenesis. Interestingly, animal 
models have suggested that semaphorins could be important paracrine factors regulating 
neurogenesis during skeletal muscle growth, development, and regeneration. A delayed 
transient increase of Sema3A expression was observed in response to muscle-induced 
injury (Tatsumi et al., 2009). In addition, a similar delay of Sema3A expression and 
secretion was seen in isolated skeletal muscle cells in response to HGF, which is an 
essential factor in muscle growth and regeneration. In our study, we have identified both 
Sema3A and Sema4C to be released by C2C12 myoblasts during differentiation.  
We have analyzed the mRNA and  protein expression of selected regulated members of the 
semaphorin family (Sema3A, Sema3E, Sema6A, and Sema7A) to investigate if their dynamic 
secretion pattern was regulated by post-transcriptional and post-translational mechanisms. 
Only minor changes were observed in the mRNA expression of Sema3A, Sema3E, Sema6A, 
and Sema7A. The mRNA expression of Sema3A and Sema7A remained constant during 
differentiation, whereas there was a slight decrease and increase in the level of Sema3E and 
Sema6A, respectively. We found that the high levels of secreted Sema3A and Sema3E at 
early stage of myotube formation did not reflect the intracellular protein levels of these 
semaphorins. Expression of Sema3A protein remained constant, whereas a slight decrease 
was observed of Sema3E protein expression in accordance with the corresponding RNA 
profile of Sema3A and Sema3E. Moreover, although the intracellular level of Sema7A 
protein was increased at day 5 of differentiation, it did not correlate with the gradually 
enhanced level of secreted protein. These finding shows that the level of secreted 
semaphorin proteins can be regulated both by post-transcriptional and post-translational 
mechanisms. This is in agreement with previous findings in which imperfect correlation 
between RNA and protein expression was observed (Bonaldi et al., 2008; de Godoy et al., 
2008; Kratchmarova et al., 2002). It also emphasizes the necessity to quantitatively 
investigate protein abundance to understand the functional role exhibited by individual 
genes and their corresponding proteins. These results clearly illustrate, that when studying 
the complex nature of the secreted factors it is important to observe both the intracellular 
level of proteins and their secretion profiles since they might differ due to post-translational 
modification or modulation of their release via the secretory pathway, turnover rate, and/or 
processing. 
4. Pitfalls of the studies on secreted proteins 
One of the major challenges in secretome studies is the identification and classification of 
secreted proteins from the total number of identified proteins from the proteomics 
experiment. Secreted proteins are released in the extracellular space via two routes: the 
classical and non-classical secretory pathways (Box 1). 
4.1 Secretory pathway, classical 
Majority of eukaryotic proteins are secreted by the classical endoplasmic reticulum (ER)-
Golgi secretory pathway consisting of a number of distinct membrane-bound compartments 
interconnected by vesicular traffic (Baines and Zhang, 2007; De Matteis and Luini; Nickel 
and Rabouille, 2009; Nickel and Wieland, 1998; Park and Loh, 2008; Pelham, 1996; Strating 
and Martens, 2009). Many basic cellular functions take place in the ER including folding of 
newly synthesized transmembrane and secretory proteins, lipid synthesis, and the storage  
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Box 1. Classification of secretory pathways 
of high concentrations of calcium ions (Marie et al., 2008; Mayor and Riezman, 2004; Sallese 
et al., 2009; Strating and Martens, 2009). In addition, post-translational modifications of 
soluble and membrane proteins occur in the ER lumen including oxidation of proline, N-
linked glycosylation, proteolytic processing, formation of disulfide bonds, oligomerization, 
and attachment of a GPI-anchor. Whereas the main functions of the Golgi apparatus include 
carbohydrate synthesis, O-linked glycosylation, processing, post-translational modification, 
and sorting both proteins and lipids (De Matteis and Luini, 2008; Marie et al., 2008; Marsh 
and Howell, 2002). Regardless of their subsequent fate, most proteins containing a N-
terminal or internal signal sequence peptide can be targeted to the ER membrane. These 
include transmembrane proteins destined to reside in the ER, plasma membrane or other 
organellar membranes as well as soluble proteins destined to the lumen of an organelle or 
for secretion. With the exception of mitochondria, nuclei, and peroxisomes, all other 
organelles receive their proteins via the ER. Signal peptides show extreme variations in their 
length and amino acid composition, but do contain three distinct domains: a positively 
charged N-terminal region, a hydrophobic core region, typically consisting of at least 6 
hydrophobic residues, and C-terminal region of polar uncharged residues (Hiller et al., 
2004). Soluble proteins are transported from the Golgi to the cell exterior via the constitutive 
secretory pathway transporting proteins directly to the cell surface or the regulated 
secretory pathway in which soluble proteins and other substances are initially stored in 
secretory vesicles, which release proteins to the extracellular space upon extracellular 
signals (Brunner et al., 2009; De Matteis and Luini, 2008; Strating and Martens, 2009). The 
latter pathway only exists in specialized secretory cells including pancreatic β-cell releasing 
insulin from secretory vesicles, nerve cells, and endocrine cells. The secretory vesicles of the 
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constitutive or regulated pathways fuse with the plasma membrane and release their 
contents by exocytosis. 
4.2 Secretory pathway, non-classical 
Although most identified extracellular proteins are secreted through the classical secretory 
pathway, emerging evidence has shown that several soluble proteins are released to the cell 
exterior via non-classical mechanisms (Nickel and Rabouille, 2009; Nickel and Seedorf, 2008; 
Prudovsky et al., 2008). For example FGF2 and IL-1β, well known extracellular proteins but 
lacking a signal peptide, are being secreted by non-classical routes either directly across the 
membrane or via vesicle intermediates. More specifically, studies investigating IL-1β 
secretion have demonstrated three alternative routes of extracellular translocation involving 
activation of caspase 1 and proteolytic processing of IL-1β. IL-1β can be released through (i) 
microvesicle shedding from the cell surface, (ii) translocation to secretory lysosomes, which 
upon fusion with the PM releases IL-1β to the cell exterior, and (iii) the caspase 1-Il-1β 
complex can be captured by endosomal vesicles creating multivesicular bodies that release 
internal vesicles as exosomes. At present, more than 20 proteins, belonging to different 
functional groups, have been described to be released to the cell exterior by non-classical 
pathways, including proteins that mainly function in the extracellular space as well as 
proteins that serve a role both intracellular and extracellular (Nickel and Seedorf, 2008; 
Prudovsky et al., 2008). Some of these proteins are constitutively secreted, whereas others 
are first released upon specific stimulation. Future studies are warranted to understand the 
biological function and regulation of the many different secretory pathways as well as the 
number and function of proteins devoid of a signal peptide but released to the extracellular 
space. Secretion of proteins by alternative pathways, which require interaction with other 
proteins and/or proteolytic activation, could impose additional levels of regulation to 
protein secretion (Nickel and Rabouille, 2009; Prudovsky et al., 2008). In addition, 
alternative secretion of signal peptide containing proteins that bypass the Golgi apparatus, 
could cause alterations in the structures of post-transcriptional modifications, such as 
glycosylation, or prevent proper proteolytic processing. This could be a way to modulate the 
biological activity of secreted proteins under certain physiological conditions. 
In addition to the two general pathways of secretion, proteins are also being released to the 
cell exterior due to apoptosis or cell leakage, thereby contaminating the pool of true secreted 
proteins. In this regard, the increased performance of MS-instrumentation not only improves 
the dynamic range for the identification of secreted proteins but also increases the number of 
identified proteins originating from the intracellular space. One example was presented in 
the study by Henningsen et al., 2011 focusing on the low molecular weight proteins. The 
quantitative mass spectrometry analysis resulted in the identification of more than 2000 
proteins however, less than 25% of these proteins were predicted to be secreted according to 
conventional database analyses based on the GO term extracellular and signal peptide 
prediction. Among the predicted secreted proteins, there were also tubulins, a number of 
ribosomal proteins, and membrane proteins that are not encountered as being truly secreted. 
Nevertheless, some of the cytoskeletal and ribosomal proteins have been demonstrated to be 
part of the exosomes and as such are being released in the extracellular environment. Major 
part of the exosomes consists of tubulins and Tsg101, which is a well-known exosome 
marker, was also identified as a secreted protein (Henningsen et al., 2011; Thery et al., 2002). 
Different tools are being used to classify the extracellular compartment in various secretome 
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studies, most commonly being assessment based on literature searches, GO-annotations 
and/or algorithms predicting secretion by classical (SignalP) or non-classical (SecretomeP) 
mechanisms (Box 2). Extraction of secreted proteins based on previous reported studies is 
extremely time-consuming considering the large number of identified proteins by today’s 
advanced MS. In addition, this will only result in the identification of proteins already shown 
by experimental data to be secreted. Isolation of secreted proteins from a large list of 
identified proteins can be done combining GO classification as extracellular and/or 
prediction of a signal peptide. However, all these tools do come with certain restrictions that 
could lead to either false positive or false negative identifications of secretion status. The 
presence of a signal peptide is not restricted to extracellular proteins. Proteins destined for 
other intracellular compartments, such as the ER or Golgi, also contains a signal peptide. In 
addition, GO terms are assigned according to different parameters, including computational 
analyses of sequences in addition to experimental data. Again, predictions based on sequence 
information could result in false positive identification of secreted proteins as well. Prediction 
tools always have their own limitations and therefore bona fide secreted proteins could also 
be lost by these tools. Most affected in this regard are the proteins released from cells by non-
conventional mechanisms whose number is still low but steadily increasing (Nickel and 
Rabouille, 2009; Prudovsky et al., 2008).  
 
Open source software and databases 
 
MaxQuant (http://maxquant.org): Advanced software program used as a tool for both 
protein identification and quantitation (Cox and Mann, 2008; Cox et al., 2009). 
 
SignalP (http://www.cbs.dtu.dk/services/SignalP): Predicting the presence of a signal 
peptide, suggesting proteins could be secreted through the classical pathway (Bendtsen et 
al., 2004b; Emanuelsson et al., 2007). 
 
SecretomeP (http://www.cbs.dtu.dk/services/SecretomeP): Prediction of proteins to be 
secreted by non-classical mechanisms (Bendtsen et al., 2004a).  
 
QuickGO provided by the Gene Ontology Annotation (GOA) group 
(http://www.ebi.ac.uk/GOA): Bioinformatics resource integrating various databases to 
assign subcellular localization and functional annotation according to GO terms (Barrell 
et al., 2009; Binns et al., 2009). 
 
GProX (http://gprox.sourceforge.net): Bioinformatics platform, which support the 
analysis and visualization of large-scale proteomics data (Rigbolt et al., 2011). 
 
Commercially available database 
 
ProteinCenter (http://www.proxeon.com): Software tool combining several data bases to 
analyze the biological context of complex proteomics experiments. 
 
Box 2. Software and databases commonly used in quantitative mass spectrometry-based 
proteomics research of secreted proteins 
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The high number of identified proteins in the QMSP experiments, which are not classified 
as secreted could be present in the extracellular space (conditioned medium) due to cell 
leakage or release of intracellular proteins from necrotic or apoptotic cells. The apoptotic 
process is a normal process that all cells grown in culture undergo at a given time point. 
However, the number of dead cells is limited since the protocol for collection of media is 
optimized such as to reduce the number of dying cells. In addition, the collected CM is 
typically filtrated using a 0.2 µm filter to ensure removal of any dead cells and thereby to 
reduce contamination from intracellular proteins. The presence of intracellular proteins 
might be explained by other structures present in the extracellular space such as exosomes 
and their cargo. Another point is that prediction of a signal peptide by itself does not 
exclude the possibility that these proteins are in fact located in other intracellular 
compartments of the cells, such as the ER and Golgi. On the other hand, an increasing 
number of proteins are being recognized as extracellular despite lacking a signal peptide 
and thought to be released through non-classical pathways (Nickel and Rabouille, 2009; 
Prudovsky et al., 2008). In the literature, more than 20 proteins devoid of any signal 
peptide have been shown to reside in the extracellular space and being released by non-
conventional mechanisms. SecretomeP (Box 2) has been designed to predict non-classical 
secreted proteins (Bendtsen et al., 2004a). For that purpose 13 known human non-classical 
secreted proteins were analyzed, but no specific sequence motif was identified to 
characterize non-classical secretion. Instead, the non-classical software for prediction was 
developed using the multiple sequence features of the 13 non-classical secreted proteins 
combined with sequence information obtained from more than 3,000 classical secreted 
proteins. Due to the limited number of identified non-classical proteins, the value of this 
prediction approach is difficult to assess. Submitting either the murine or human 
sequence of galectin-1 to SecretomeP resulted in probability score of < 0.5, thereby 
exemplifying a false negative identification. Galectin-1 is a well-known extracellular 
protein lacking a signal peptide but released by non-conventional ways (Hughes, 1999; 
Sango et al., 2004). On the other hand HMGB1, also not containing a signal peptide and 
mainly known for its role as a chromatin modifying protein, is also serving an 
extracellular function suggesting that proteins with typically intracellular functions could 
also be released to the cell exterior (Bonaldi et al., 2003 2002; Gardella et al., 2002). Future 
studies will help to elucidate how many proteins deficient in a signal peptide are being 
released to the extracellular space. Classifying proteins as extracellular based on GO 
annotation can also lead to false negative or false positive classifications. GO annotation 
are based both on experimental data but also on computational analysis of sequence 
information. With the increasing number of biomarker directed studies analyzing 
biofluids by mass spectrometry, the number of classified secreted proteins is steadily 
increasing. The increased number of identified secreted proteins could be due to 
improvements of mass spectrometry technology, which increased the overall sensitivity of 
protein identification, but could also be artifacts derived from dead cells floating around 
in the circulation.  
In summary, combination of different tools and manually curated data might be beneficial 
when validating the large lists obtained from QMSP experiments focusing on secreted 
factors. Nevertheless, release of cellular components can occur via microvesicles and/or 
exosomes adding to the complexity of secretome studies, thus some of the factors commonly 
counted as contaminants might be truly secreted ones. 
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4.3 Serum contaminants 
Mammalian cell culture models are broadly used in proteomics experiments and often 
contamination with bovine serum proteins, originating from the serum supplement used for 
the culturing of cells, is observed in the results from the mass spectrometric analyses. 
Naturally, when studying the proteins released by specific types of cells, one of the biggest 
challenges remains the presence of serum proteins that could interfere with the 
identification of proteins secreted by the cells. Presence of serum proteins in the sample can 
disrupt the concentration of the CM as well as interfere with the MS analysis, masking the 
presence of other proteins. It has been estimated that a 10% FBS serum complement, which 
is commonly added to the culture media, adds 5-6 mg/ml protein to the media and even 
extensive washing of the cells might not be sufficient to remove the bovine proteins to levels 
below the detection limit of the mass spectrometer (Bunkenborg et al., 2010). The sera-
derived proteins could be falsely identified as proteins being secreted by the cells due to 
sequence homology between species. One suggested solution to exclude bovine 
contaminants was based on expanding the database to include both the human and the 
bovine proteome. Another alternative is to extend the database to include known bovine 
contaminants as a common contaminant list, which is already incorporated in the data 
analysis by programs such as MaxQuant (Bunkenborg et al., 2010; Henningsen et al., 2011; 
Henningsen et al., 2010). In this way, it is possible to exclude the proteins recognized as 
contaminants from the initial list of identifications and thereby to minimize the number of 
identifications originating from sera proteins. Nevertheless, the SILAC strategy is so far the 
best known applicable method to investigate secreted factors by a given type of cells since 
the metabolic labeling makes it possible to distinguish cell-derived secreted proteins, as 
these are SILAC labeled, from residual sera proteins. Only proteins that are synthesized in 
the cells in the presence of the heavy SILAC amino acid will be labeled, thereby these are 
easily distinguished from sera contaminants, which remain unlabeled. In addition, the 
accuracy of protein quantitation could also be compromised by the presence of sera proteins 
in the samples. It is therefore advisable to perform a replica experiment with reverse SILAC 
labeling strategy (Schulze and Mann, 2004), which is an easy solution to overcome this 
possible drawback as well as to ensure high quality quantitation of bona fide secreted 
proteins. 
4.4 Post-translational modifications of secreted proteins 
Glycosylation of secreted proteins is one of the most abundant post-translational 
modifications (PTM), which affects the proteins folding, stability, and activity. The 
oligosaccharides are linked to the proteins via asparagine (N-linked) or serine/threonine (O-
linked) residues. Enrichment of secreted proteins through their glycan structures is an 
alternative experimental strategy for the identification of secreted proteins. Various types of 
enrichment methods have been utilized to capture glycosylated proteins, one of the 
common approaches being lectin affinity chromatography. In an elegant study by Zielinska 
et al., the combinatorial use of optimized lectin-based enrichment step, subcellular 
fractionation, deglycosylation assays, SILAC labeling, advanced mass spectrometry 
followed by integrative bioinformatic analyses  resulted in the identification of 6367 N-
glycosylation sites on 2352 proteins in four mouse tissues and blood plasma. N-
glycosylation was found to occur exclusively on secreted proteins, on the extracellular face 
of membrane proteins, and on the lumenal side of ER, Golgi apparatus, and lysosomes 
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(Zielinska et al., 2010). In a complementary study using formalin-fixed paraffin-embedded 
tissue samples, 1500 N-glycosylation sites were found underlying the increased sensitivity 
and accuracy of the mass spectrometry-based proteomics for identification of post-
translationally modified proteins, even in fixed samples. The comparison of fresh tissue 
using SILAC-labeled mouse (Kruger et al., 2008) with the paraffin embedded tissue showed 
no significant qualitative or quantitative differences between these samples, either at protein 
or peptide level, thereby permitting the use of this methodology in clinical studies 
(Ostasiewicz et al., 2010).  
Hydroxyproline is another type of PTM that is identified predominantly on components of 
the extracellular matrix and especially on different types of collagens. We have recently 
reported the identification of 299 unique high-confidence hydroxyproline sites from 48 
distinct secreted proteins in muscle cells, representing the largest data set so far on this 
proline modification. 231 of the modified prolines were located on various collagen types 
with a large variation of the number of modified sites per individual protein. The number 
ranged from 1 site on collagen alpha-3 type VI to more than 70 on collagen alpha-1 type I, 
highlighting the importance of the proline modification in maintaining the structure of the 
collagens. Motif sequence analysis revealed the canonical motif previously reported for 
collagen proteins as well as a novel hydroxyproline motif. Modified peptides containing 
hydroxyproline sites extend over more than 40 proteins including fatty acid binding protein 
(FABP), several components of the ECM such as SPARC, fibronectin, Lama2, perlecan, and 
different inhibitors of proteolytic enzymes such as serine protease inhibitors (serpinf1 and 
serphinh1) and the metalloproteinase inhibitor 2 (Timp2). These results indicate that 
hydroxyproline could serve as an important secondary modification to confer protein 
stability and interaction with other secreted proteins. 
5. Conclusion 
The rapid development of MS-instrumentation combined with the advances of quantitative 
proteomics strategies, such as SILAC, has had a tremendous impact in the analysis of 
complex biological systems. QMSP is increasingly becoming an essential approach, 
especially for the characterization of entire secretomes and generation of dynamic 
quantitative profiles of secreted factors during the course of cellular differentiation or in 
response to drugs, inhibitors, and modulators. Although there have been a marked 
improvement of the proteomics strategies to characterize secretomes, many challenges still 
remain: minimizing the suppressive effect of growth supplements present in the sample 
during MS analyses, identification of whole tissue secretomes, collection of samples under 
specific conditions to avoid induction of cell death, identification of low abundant low 
molecular weight proteins. However, the most critical point presented by secretome studies 
today is to isolate the bona fide secreted proteins and to validate the obtained results. 
Integrative approaches that combine highly advanced proteomics methodology followed by 
biological functional analyses can lead to the creation of secretome maps that underline 
tissue crosstalk and communication. 
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